In Person

BIO Convention 2019 Digital Health Track

June 3 – 6, 2019
Event details
June 3 – 6, 2019
12:00 am
Philadelphia, PA

Event summary

Join Cooley and BIO Digital Health Track chair Wain Fishburn for three days of programming with leading digital health investors, thought leaders and KOLs. Featured sessions include:

DTx: Struggles, Lessons, & Best Practices for Shifting to Digital Therapy 
Monday, June 3, 2:30 pm – 3:45 pm

As healthcare shifts towards digital, the spotlight is shining on the emerging field of Digital Therapy (DTx). With unique mechanisms of action and proven outcomes, digital therapies have enormous potential. Join this panel of seasoned dealmakers to learn how can BioPharma can participate. Where should R&D reside? What partners are needed and what lessons have we learned so far?

Speakers:
• Wainwright Fishburn, Partner, Cooley
• Ilana Brand, Vice President, Business Development, Cooley
• Chris Bergstrom, Partner and Digital Health Lead
• Dr. Kal Patel, President, BrightInsight, a Flex Company


Investors Corner: Perspectives and Predictions for 2019 and Beyond
Tuesday, June 4, 2:00 pm – 3:00 pm

Join Wainwright Fishburn for a digital health market snapshot, followed by an in-depth discussion with investors on where the sector is headed. Digital health funding has reached more than $18B invested in 1,000+ deals over the last three years. The sector is maturing, and select early entrants have achieved market validation along with viable regulatory pathways. Our panel of active venture capital investors will share their perspectives on market trends and predictions for the breakout companies and sectors in 2019 and beyond.

Speakers:
• Wainwright Fishburn, Partner, Cooley
• 
Kapila Ratnam, Partner, NewSpring Capital 
• 
Dan Gebremedhin, MD, Partner, Flare Capital
• 
Brett Cook, Principal, F-Prime Capital


Digital Integration in Healthcare:  Real-World Scenarios from Leading Healthcare Institutions and Fireside Chat with Carina Edwards, CEO, Quil 
Tuesday, June 4, 3:15 pm – 4:45 pm

Leading healthcare institutions in the Philadelphia region discuss how they are leveraging digital tools to streamline performance and improve measurable outcomes. What are some of the ways that hospitals and providers are managing chronic care and preventing readmissions at scale? What types of technology-based interventions are helping these institutions achieve these goals? Clinicians and thought leaders will discuss real-world scenarios using mobile technologies and digital solutions to improve the lives of patients.

Moderator: Geoff Starr, Partner, Cooley
Speakers:
• Roy Rosin, Chief Innovation Officer, Penn Medicine 
• 
Dr. Francois Simon, Professor Emerita, Columbia University Mailman School of Public Health; Author, Managing Biotechnology: From Science to Market in the Digital Age 
• 
Dr. Adam Dicker,MD, PhD is Senior Vice President, Professor and Chair, Department of Radiation Oncology at Sidney Kimmel Cancer Center at Thomas Jefferson University 
• 
Fireside Chat with Carina Edwards, CEO, Quil

 

Register to attend


This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.